EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, WVE: Wave Life Sci Ord Sh

12 Nov 25 15:12
LAST:

6.965

CHANGE:
 0.30		OPEN:
7.390		HIGH:
7.390		ASK:
36.000		VOLUME:
1.26M
CHG(%):
4.06		PREV:
7.260		LOW:
6.860		BID:
20.150		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Nov 257.3907.3906.8606.9651.26M
11 Nov 257.0007.4106.9007.2602.95M
10 Nov 257.8008.0806.7237.0504.0M
07 Nov 257.7107.9707.2407.8603.28M
06 Nov 258.0608.1407.8707.8801.98M
05 Nov 258.0008.0707.7008.0401.98M
04 Nov 258.0208.2707.9508.0102.13M
03 Nov 258.9009.1308.2008.3104.22M
31 Oct 258.2909.0908.1759.0405.25M
30 Oct 258.3708.6808.2208.3004.18M

COMPANY PROFILE

Name:Wave Life Sci Ord Sh
About:Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-N531, an exon skipping oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.
Sector:Healthcare
Industry:Biotechnology
Address:Marina One East Tower, Singapore, Singapore, 018936
Website:https://wavelifesciences.com
CUSIP:Y95308105
CIK:0001631574
ISIN:USY953081053
FIGI:BBG00B642V54

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-11.87 
Forward P/E:-9.22 
PEG Ratio:-0.49 
Price to Sales:15.32 
Price to Book:10.10 
Profit Margin:-1.38 
Operating Margin:-6.07 
Return on Assets:-0.39 
Return on Equity:-1.71 
EPS Ratio:-0.80 
Revenue:93.95M 
Shares:159.23M 
Market Cap:1.109B 

TECHNICAL INDICATORS

MA5:7.416.3%
MA10:7.8713.0%
MA20:7.7411.2%
MA50:7.477.2%
MA100:7.8913.3%
MA200:8.0315.3%
RSI14:49.18
WPR14:-100.00 
MTM14:-0.16
ROC14:-0.02 
ATR:0.71 
Week High:8.1416.9%
Week Low:6.723.6%
Month High:9.7540.0%
Month Low:6.7215.3%
Year High:16.71139.9%
Year Low:5.2831.9%
Volatility:20.01